By screening a cDNA library derived from melanoma tissue with sera from multiple melanoma patients it was found that high-titer IgG antibodies to HOM-Mel-40/SSX2 were found in approximately 10% of patients with melanoma (10/89), whereas SSX2 responses were absent in sera from healthy controls (0/41). Here, SSX2 is linked to melanoma.